Phase I, Open Label Drug-Drug Interaction Study in Healthy Volunteers to Evaluate the Effect of KALETRA (Lopinavir-Ritonavir) on GSK706769 Pharmacokinetics and to Evaluate the Pharmacokinetics of a New Oral Formulation of GSK706769.

Trial Profile

Phase I, Open Label Drug-Drug Interaction Study in Healthy Volunteers to Evaluate the Effect of KALETRA (Lopinavir-Ritonavir) on GSK706769 Pharmacokinetics and to Evaluate the Pharmacokinetics of a New Oral Formulation of GSK706769.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs GSK 706769; Lopinavir/ritonavir
  • Indications HIV infections; HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Jun 2012 Actual patient number 17 added as reported by ClinicalTrials.gov.
    • 18 Dec 2008 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 18 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top